Skip to main content

Olema Pharmaceuticals, Inc.

OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001750284

In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.

13F holders, Q2 2024

Institutional positions in Olema Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
129
+4 vs. Q1 2024
Shares held
57.9M
+1.87M (+3.3%) vs. Q1 2024
Total value
$626.9M
−$7.75M (−1.2%) vs. Q1 2024
New holders
29
52 more added
Sold out
25
34 more reduced

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting OLMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 129 institutions
Q1 2021: 74 institutionsQ2 2021: 69 institutionsQ3 2021: 76 institutionsQ4 2021: 97 institutionsQ1 2022: 91 institutionsQ2 2022: 76 institutionsQ3 2022: 73 institutionsQ4 2022: 67 institutionsQ1 2023: 66 institutionsQ2 2023: 87 institutionsQ3 2023: 97 institutionsQ4 2023: 113 institutionsQ1 2024: 126 institutionsQ2 2024: 129 institutionsQ3 2024: 130 institutionsQ4 2024: 157 institutionsQ1 2025: 134 institutionsQ2 2025: 123 institutionsQ3 2025: 126 institutionsQ4 2025: 200 institutionsQ1 2026: 195 institutionsQ2 2026: 185 institutions
Value heldQ2 2024: $626.9M
Q1 2021: $1.16BQ2 2021: $1.05BQ3 2021: $1.01BQ4 2021: $359.5MQ1 2022: $155.2MQ2 2022: $139.2MQ3 2022: $92.1MQ4 2022: $81.6MQ1 2023: $116.1MQ2 2023: $329.2MQ3 2023: $584.4MQ4 2023: $717.1MQ1 2024: $635.2MQ2 2024: $626.9MQ3 2024: $700.3MQ4 2024: $415.4MQ1 2025: $248.0MQ2 2025: $300.5MQ3 2025: $668.2MQ4 2025: $2.27BQ1 2026: $1.51BQ2 2026: $1.28B
Institutions holding OLMA and their total value by quarter
QuarterHoldersValue
Q2 2026185$1.28B
Q1 2026195$1.51B
Q4 2025200$2.27B
Q3 2025126$668.2M
Q2 2025123$300.5M
Q1 2025134$248.0M
Q4 2024157$415.4M
Q3 2024130$700.3M
Q2 2024129$626.9M
Q1 2024126$635.2M
Q4 2023113$717.1M
Q3 202397$584.4M
Q2 202387$329.2M
Q1 202366$116.1M
Q4 202267$81.6M
Q3 202273$92.1M
Q2 202276$139.2M
Q1 202291$155.2M
Q4 202197$359.5M
Q3 202176$1.01B
Q2 202169$1.05B
Q1 202174$1.16B

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Olema Pharmaceuticals, Inc.; share changes are against Q1 2024.

Institutions holding OLMA in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Deutsche Bank AG253,874$2.75M0.00%+4,844+1.9%Added
Affinity Asset Advisors, LLC275,000$2.98M0.47%+275,000New
Adage Capital Partners GP, L.L.C.325,000$3.52M0.01%−135,000−29.3%Reduced
Morgan Stanley335,571$3.63M0.00%−162,555−32.6%Reduced
Northern Trust Corp344,082$3.72M0.00%−5,075−1.5%Reduced
Goldman Sachs Group Inc401,105$4.34M0.00%−35,926−8.2%Reduced
Ameriprise Financial Inc441,066$4.77M0.00%+127,820+40.8%Added
Silverarc Capital Management, LLC546,863$5.92M1.46%+31,546+6.1%Added
Ghost Tree Capital, LLC550,000$5.95M2.07%+350,000+175.0%Added
Marshall Wace, LLP588,996$6.37M0.01%+41,193+7.5%Added
Boxer Capital, LLC650,000$7.03M0.37%+650,000New
Victory Capital Management Inc774,792$8.38M0.01%+164,143+26.9%Added
Great Point Partners LLC796,880$8.62M1.65%+796,880New
Woodline Partners LP852,554$9.22M0.09%+102,275+13.6%Added
Wellington Management Group LLP905,257$9.79M0.00%+69,644+8.3%Added
Polar Capital Holdings Plc1,000,000$10.8M0.06%+250,000+33.3%Added
Candriam Luxembourg S.C.A.1,058,673$11.5M0.07%+705,655+199.9%Added
Geode Capital Management, LLC1,060,099$11.5M0.00%+220,754+26.3%Added
Dimensional Fund Advisors LP1,684,924$18.2M0.00%−251,233−13.0%Reduced
Vivo Capital, LLC1,873,704$20.3M1.87%00.0%Unchanged
State Street Corp1,947,977$21.1M0.00%−1,230,450−38.7%Reduced
MPM Oncology Impact Management LP2,654,867$28.7M4.46%+701,177+35.9%Added
Vanguard Group Inc2,742,664$29.7M0.00%+334,976+13.9%Added
Logos Global Management LP3,208,875$34.7M4.00%−1,175,000−26.8%Reduced
Point72 Asset Management, L.P.3,211,927$34.8M0.11%+3,211,927New
BlackRock Inc.3,999,518$43.3M0.00%+782,964+24.3%Added
Deep Track Capital, LP4,000,000$43.3M1.29%+774,581+24.0%Added
Paradigm Biocapital Advisors LP7,903,600$85.5M3.27%00.0%Unchanged
BVF Inc9,135,893$98.9M2.77%00.0%Unchanged
Braidwell LP0$00.00%−704,344−100.0%Sold out
Altium Capital Management LP0$00.00%−605,000−100.0%Sold out
Ally Bridge Group (NY) LLC0$00.00%−559,035−100.0%Sold out
Exome Asset Management LLC0$00.00%−143,400−100.0%Sold out
Monashee Investment Management LLC0$00.00%−135,000−100.0%Sold out
Acadian Asset Management LLC0$00.00%−103,179−100.0%Sold out
Millennium Management LLC0$00.00%−88,257−100.0%Sold out
VR Adviser, LLC0$00.00%−77,042−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−67,507−100.0%Sold out
Cinctive Capital Management LP0$00.00%−56,518−100.0%Sold out
Algert Global LLC0$00.00%−33,580−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−32,700−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−27,013−100.0%Sold out
Susquehanna Fundamental Investments, LLC0$00.00%−15,565−100.0%Sold out
Entropy Technologies, LP0$00.00%−14,246−100.0%Sold out
E Fund Management Co., Ltd.0$00.00%−13,927−100.0%Sold out
American International Group, Inc.0$00.00%−13,231−100.0%Sold out
Walleye Capital LLC0$00.00%−11,966−100.0%Sold out
Sherbrooke Park Advisers LLC0$00.00%−11,212−100.0%Sold out
Quest Partners LLC0$00.00%−8,215−100.0%Sold out
Metropolitan Life Insurance Co0$00.00%−1,545−100.0%Sold out
Truvestments Capital LLC0$00.00%−1,323−100.0%Sold out
Comerica Bank0$00.00%−354−100.0%Sold out
US Bancorp0$00.00%−157−100.0%Sold out
Nelson, Van Denburg & Campbell Wealth Management Group, LLC0$00.00%−6−100.0%Sold out
Credit Suisse AG––––Not filed